RxSight, Inc.
RXST
16 insider filings · Latest: Jun 17, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Oct 1 8:24 PM | SHELLEY B THUNEN | Proposed Sale | 15,000 | $48.45 | $726.7K | — | View → |
| Sep 30, 2024 | Sep 30 8:14 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $49.02 | $151.9K | — | View → |
| Sep 26, 2024 | Sep 26 8:09 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,105 | $49.29 | $153.1K | — | View → |
| Sep 23, 2024 | Sep 23 8:08 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $52.67 | $163.3K | — | View → |
| Sep 20, 2024 | Sep 20 8:08 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $53.19 | $164.9K | — | View → |
| Sep 17, 2024 | Sep 17 8:15 PM | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $56.11 | $173.9K | — | View → |
| Nov 12, 2024 | — | ILYA GOLDSHLEGER | Proposed Sale | 1,330 | $46.13 | $61.4K | — | View → |
| Nov 4, 2024 | — | ILYA GOLDSHLEGER | Proposed Sale | 3,100 | $51.05 | $158.2K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Apr 20 8:19 PM | Ilya GoldshlegerChief Operating Officer | Option Exercise | 12,489 | $4.13 | 5(D) | View → |
| Feb 28, 2026 | Mar 4 1:24 AM | Mark WilterdingChief Financial Officer | Option Exercise | 20,441 | — | 143,087(D) | View → |
| Feb 28, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Option Exercise | 6,261 | — | 2,500(D) | View → |
| Feb 27, 2026 | Mar 4 1:22 AM | Scott GainesChief Customer Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:21 AM | Ilya GoldshlegerChief Operating Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:20 AM | Eric WeinbergExhibit 24 - Power of Attorney Chief Business Development Officer | Grant/Award | 32,218 | — | 32,218(D) | View → |
| Feb 27, 2026 | Mar 4 1:19 AM | Ronald M Kurtz MDDirector, President & CEO | Grant/Award | 80,545 | — | 80,545(D) | View → |
| Jan 12, 2026 | Jan 30 9:14 PM | Mark WilterdingChief Financial Officer | Grant/Award | 422,298 | $10.09 | 163,528(D) | View → |